Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03970252
Title Nivolumab in Combination With Chemotherapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center

pancreatic adenocarcinoma


Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin + Nivolumab + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.